BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Mergers and Acquisitions (World)
RedHill Biopharma Ltd. (RDHL) Acquires Technology From University of Minnesota As Part Of Ongoing RHB-104 Phase 3 Crohn's Program 12/18/2014
Shire (SHPGY) May Spend AbbVie (ABBV) Breakup Fee On NPS Pharmaceuticals, Inc. (NPSP); NPS Surges On Rumor 12/18/2014
KCR Acquires Project Portfolio From Ukrainian CRO AXIS 12/18/2014
UCB SA Terminates $1.53 Billion Sale Of Generic Drug Unit To Buyout Firms 12/17/2014
Evolva A/S Unloads EV-035 Series To Emergent BioSolutions (EBS) For $70.5 Million Plus 12/17/2014
Novartis AG (NVS) Takes Stake In Israeli Biopharma BioLine; Makes $10 Million Investment 12/16/2014
Renmatix Acquires Sweden-Based REAC Fuel's Intellectual Property 12/16/2014
Sosei Group Corporation Acquires Jitsubo, A Leading Japanese Peptide Technology Company 12/12/2014
Cipla Ltd. Sells Stake In Jiangsu Cdymax Pharma For $18.5 Million 12/12/2014
Interim CEO Says Sanofi (SAN.PA) Continuing Diversification, Eyeing Acquisitions 12/10/2014
China, South Korea OK GlaxoSmithKline (GSK)'s $43B Covidien (COV) Buy 12/5/2014
Speculation Mounts That Pfizer (PFE) Will Up Bid For AstraZeneca PLC (AZN) As Cooling Off Period Ends 12/5/2014
Forbion Announces Sale Of Portfolio Company PneumRx Inc. To BTG plc (BTG.L) For Up To EUR 385M (USD 475M) 12/4/2014
Roche (RHHBY) Acquires Ariosa Diagnostics, Inc. And Enters The Non-Invasive Prenatal Test (NIPT) And Cell-Free DNA Testing Services Markets 12/3/2014
Shanghai Fosun Buys 65% Stake In Suzhou Erye Pharma 12/3/2014
Alizé Acquires Exclusive Worldwide Rights On A New Peptide To Tackle Bone Diseases 12/3/2014
Otsuka Pharmaceutical Co., Ltd. Buys AVANIR Pharmaceuticals (AVNR) For $3.5 Billion 12/2/2014
Pfizer (PFE) Announces Completion Of Merger With Wyeth 12/2/2014
European Commission (EC) Regulators Mull Novartis AG (NVS), GlaxoSmithKline (GSK) Deals As January Deadline Looms 12/1/2014
Contera Pharma Announces Acquisition By Korean Bukwang Pharmaceutical 12/1/2014
Imaflex Acquires Controlled-Release Agricultural Mulch Film Assets From Bayer AG (BAYZF) 12/1/2014
Regen BioPharma Acquires University of Toronto Cancer Stem Cell Intellectual Property 11/25/2014
AbbVie (ABBV) Acquires Manufacturing Facility In Singapore; Further Expands Capabilities In Asia 11/21/2014
Endo Pharmaceuticals (ENDP) Announces Early Termination Of HSR Act Waiting Period In Connection With Its Proposed Acquisition Of Auxilium Pharmaceuticals (AUXL) 11/19/2014
Recipharm AB Bags Lusomedicamenta For $140 Million 11/14/2014
Jubilant Life Sciences (JOL) Seeks To Complete Buyout Of U.S.-Based Cadista For Up To $33.2 Million 11/14/2014
PE Firm To Bid For GlaxoSmithKline (GSK)'s $3 Billion Mature Drugs Portfolio 11/14/2014
Sanofi (SAN.PA) Unloads Large Office In India 11/13/2014
Nuvo Research Inc. (NRI.TO) Reacquires Pennsaid® 2% Rights To South America, Central America, South Africa And Israel 11/13/2014
Thailand-Based SCG Acquires Stake In Liechtenstein-Based Research Company Lysando AG 11/12/2014
AstraZeneca PLC (AZN) Is Building Value Without Pfizer (PFE): CEO 11/11/2014
Johnson & Johnson (JNJ) Chief Eyes Acquisitions In China 11/10/2014
UCB Group (UCBJF.PK) Divests U.S. Generics Unit For $1.53 Billion 11/7/2014
GVK BIO Signs Definitive Agreement To Acquire Vanta Bioscience 11/6/2014
Perrigo Company (PRGO) Snatches Up Omega Pharma NV (0OMEP.BR) For $4.5 Billion 11/6/2014
AstraZeneca PLC (AZN) Builds Cancer Immunotherapy Capabilities With $150 Million Definiens AG Buy 11/4/2014
Univar Expands in Brazil Market With Acquisition Of D'Altomare Quimica Ltda. 11/4/2014
Taiyo Pacific Partners Becomes Major Shareholder In Peptidream With Stake Over 5% 11/4/2014
AbbVie (ABBV) Not Looking For Massive Deals After Abandoning Shire 11/3/2014
Actavis (ACT) And Durata Therapeutics, Inc.  (DRTX) Receive U.S. FTC Clearance For Actavis' Proposed Acquisition Of Durata 11/3/2014
Deal-Starved Perrigo Company (PRGO) In Exclusive Talks To Buy $5 Billion+ Omega Pharma NV (0OMEP.BR) 10/31/2014
Bayer AG (BAYZF) Hunts For More Deals After Bulking Up Consumer Care 10/30/2014
Novartis AG (NVS) Sells Flu Vaccine Business For $275 Million To CSL Limited (CMXHF.PK) 10/28/2014
Luye Pharma Pays $390 Million For Remaining 42% Of Beijing Jialin Pharma 10/28/2014
Zogenix, Inc. (ZGNX) Snags U.K.-Based Brabant Pharma In $35 Million Cash-Stock Deal 10/27/2014
Private Equity Eyes $13 Billion Bayer AG (BAYZF)'s Plastics Business 10/24/2014
Mylan Inc. (MYL), Abbott Laboratories (ABT) Tweak $5 Billion Tax Inversion Deal 10/23/2014
Actavis (ACT) Will Compete With Sanofi (SAN.PA) For $5.1 Billion Omega Pharma NV (0OMEP.BR) Deal 10/21/2014
Lupin Ltd. (LUPN.BO) Scouts For Acquisitions In U.S. 10/21/2014
Shire Goes Shopping After AbbVie (ABBV) Deal Falls Through 10/21/2014
AbbVie (ABBV) Officially Abandons Shire 10/21/2014
Therapix Signs Non-Binding Agreement to Acquire Dekel Pharmaceuticals Ltd. 10/21/2014
Fresenius AG, Buyout Groups Eye Danone Medical Nutrition Unit 10/20/2014
AbbVie (ABBV) Board Officially Abandons $55 Billion Shire Merger 10/17/2014
Horizon Biopharm Pays $45 Million Cash For U.S. Rights To PENNSAID® 2% 10/17/2014
DiaGenic ASA: Completed Acquisition Of NEL Hydrogen – Company Name And Ticker To Be Changed 10/17/2014
Virax To Acquire Deep AKT Inhibitor Portfolio Already In Phase 1b/2 Breast & Phase 1b Ovarian Cancer Trials 10/17/2014
Shire Plummets As AbbVie (ABBV) Reconsiders $55 Billion Takeover Bid 10/16/2014
MorphoSys AG Acquires Lanthipeptide Technology From Lanthio Pharma 10/15/2014
Analysts Still See AstraZeneca PLC (AZN) As Viable Takeover Target 10/15/2014
Geographic Split Likely For GlaxoSmithKline (GSK) Mature Drugs Sale 10/15/2014
Oxford BioMedica PLC (OXB.L) Acquires Windrush Court Office And Laboratory Facilities 10/13/2014
GlaxoSmithKline (GSK) Takes A 25% Stake In Aspen Pharmacare Ltd. Japanese Unit 10/9/2014
Endo International plc (ENDP) Pays $2.6 Billion For Auxilium Pharmaceuticals (AUXL), Auxilium Drops QLT Inc. (QLTI) Deal 10/9/2014
DiaGenic ASA Signed Final Agreement To Acquire NEL Hydrogen AS – Extended Announcement 10/8/2014
Teva Pharmaceutical Industries Limited (TEVA) To Stop R&D In Cancer And Women's Health; 14 Pipeline Projects To End, Divest 10/7/2014
Top Managers Argue Over What To Do With Sanofi (SAN.PA)'s $8 Billion Drug Portfolio 10/7/2014
Analyst Dismisses Teva Pharmaceutical Industries Limited (TEVA)-Mylan Inc. (MYL) Merger Rumor 10/7/2014
Week in Review: WuXi PharmaTech Co., Ltd. Acquires XenoBiotic Laboratories, Inc. , A US-China CRO 10/6/2014
Actavis (ACT) Finally Makes A Move, Pays $675 Million For Durata Therapeutics, Inc.  (DRTX) 10/6/2014
Salix Pharmaceuticals, Ltd. (SLXP) Linked With Actavis (ACT) After Calling Off Cosmo Pharmaceuticals S.p.A. Merger Amid Inversion Crackdown 10/3/2014
Prima Biomed (PRR.AX) Secures $37.4 Million To Fund Immutep S.A. Acquisition 10/2/2014
Immutep S.A. Picks Up Prima Biomed (PRR.AX) For $28 Million 10/2/2014
Consort Medical Scoops Up Aesica For $374 Million 10/1/2014
WuXi PharmaTech Co., Ltd. Laboratory Testing Division Expands In U.S. With Acquisition Of XenoBiotic Laboratories, Inc. 10/1/2014
Recipharm AB Completes Acquisition Of Corvette Pharmaceutical Services Group For SEK1.1 Billion 10/1/2014
Strides Arcolab Limited Snags Shasun Pharma In All Stock Deal Worth Over $221 Million 9/30/2014
Chiltern International Ltd. Acquires Pacific Clinical Research Pte Limited And Expands Operations And Therapeutic Depth In Asia-Pacific 9/29/2014
Daiichi Sankyo, Inc. (4568.t) Boosts Cancer Pipeline With $410 Million Ambit Biosciences Buy 9/29/2014
Hikma Pharmaceuticals Eyeing $1 Billion Bid For U.S. Rival CorePharma LLC 9/29/2014
Pfizer (PFE) Approached Actavis (ACT) For Possible Merger 9/24/2014
Merck KGaA (MKGAF.PK) To Pay $17 Billion For St. Louis-Based Sigma-Aldrich Corporation (SIAL) 9/23/2014
Bionomics Limited (BNO.AX) Acquires Prestwick Chemical 9/23/2014
Hikma Pharmaceuticals Completes Acquisition Of Ben Venue Laboratories Manufacturing Site 9/17/2014
Auxilium Pharmaceuticals (AUXL) Institutes "Poison Pill" To Fend Off $2.2B Endo Pharmaceuticals (ENDP) Offer 9/17/2014
Illinois-Based Akorn, Inc. (AKN) Eyes $2 Billion UCB SA Unit In Potential Tax Inversion Deal 9/12/2014
ReproCELL Acquires The iPS Cell Business Unit Of Stemgent, Inc. 9/9/2014
Cellectis (ALCLS) Announces The Closing Of The Sale Of Its Swedish Subsidiary Cellectis AB To Takara Bio 9/4/2014
China Biologic Products Completes Transaction To Acquire Additional Equity Stake In Guizhou Taibang 9/4/2014
Mercachem Holding B.V. To Acquire Prague Business From Synthon 9/3/2014
AstraZeneca PLC (AZN) Pops On Possibility Of Another Pfizer (PFE) Bid; Start Of New Cancer Trial 9/2/2014
Luye Pharma Buys Majority Stake In Beijing Jialin For $599 Million 8/29/2014
Bayer AG (BAYZF), Boehringer Ingelheim Corporation, Perrigo Company (PRGO), And Sanofi (France) (SAN.PA) Linked To Omega Pharma NV (0OMEP.BR) Sale; Deal Could Cost More Than $5.3 Billion 8/29/2014
Novo Nordisk A/S (NVO) Prefers To Grow On Its Own, Not Buy Others: CEO 8/27/2014
Synexus Further Expands Its Global Footprint With An Acquisition In South Africa 8/27/2014
Disappointment Looms As Roche (RHHBY) Drops Plans To Bid For The Rest Of Chugai Pharmaceutical Co., Ltd. (Japan) 8/26/2014
Roche (RHHBY) Pays $8.3 Billion For Bay Area's InterMune, Inc. (ITMN), Pledges To Keep Employees 8/26/2014
China Biologic Products Pays $87 Million For Additional 20 Percent Stake In Subsidiary 8/25/2014
Pfizer (PFE) Eyes Possible Actavis (ACT) Bid Whilst Weighing Next Steps Over AstraZeneca PLC (AZN) 8/22/2014
Mylan Inc. (MYL) Makes Second Round Of Bidding For GlaxoSmithKline (GSK) Drug Portfolio 8/22/2014
DrugDev Acquires Award-Winning Trialnetworks Platform, Launches Innovation Lab, Unveils Investigator Databank Website And Reaches $1 Billion In Global Site Payments In First Half Of 2014 8/21/2014
Sweden's Recipharm AB Pays $160 Million For Corvette Pharmaceutical Services Group 8/19/2014
Confirmed: Novartis AG (NVS) To Invest In Gamida Cell Ltd., Could Buy Out Company In $635 Million Cancer Deal 8/19/2014
Conflicting Reports Surface Over Roche Holding AG (RHHBF.PK)'s $10 Billion Deal, Chugai Pharmaceutical Co., Ltd. (Japan) Denies Talks 8/19/2014
Deal Is Back On: Novartis AG (NVS) To Invest Heavily In Gamida Cell Ltd. Before Acquisition 8/18/2014
InterMune, Inc. (ITMN) Goes Up On The Block; GlaxoSmithKline (GSK), Roche (RHHBY), Sanofi (France) (SAN.PA) Line Up 8/18/2014
Mallinckrodt Pharmaceuticals (MNK) Completes Acquisition Of Questcor Pharmaceuticals, Inc. (QCOR) 8/15/2014
Roche (RHHBY) May Gobble Up The Rest Of Chugai Pharmaceutical Co., Ltd. (Japan) For $10 Billion 8/15/2014
Miltenyi Biotec, Inc. Acquires Gene Therapy Assets From Lentigen Corporation 8/14/2014
Merck KGaA (MKGAF.PK) CEO Eyes Interesting Takeover Targets 8/14/2014
SkyePharma Inc. (SKYE) Acquires A Novel Inhaled Therapy Platform 8/13/2014
uniQure Acquires Cardiology Gene Therapy Company InoCard 8/12/2014
Boehringer Ingelheim Vetmedica, Inc. Acquires Licensing Rights For Artilysin® Technology From Lysando AG 8/12/2014
Endo International plc (ENDP) Completes Acquisition Of DAVA Pharmaceuticals 8/7/2014
After Layoff News, Novartis AG (NVS)'s New York Campus Officially Goes On The Market 8/7/2014
AstraZeneca PLC (AZN), Shire Slip As The U.S. Looks To Stop Tax Inversion Deals 8/7/2014
Analysts Believe Vulnerable GlaxoSmithKline (GSK) May Be Pfizer (PFE)'s Plan B 8/6/2014
Roche (RHHBY) Bags Santaris Pharma A/S In Deal Worth $450 Million 8/5/2014
Private Equity Firms Mull $10 Billion Merger Of Older GlaxoSmithKline (GSK), Sanofi (France) (SAN.PA) Brands 8/4/2014
Hedge Funds Bet AstraZeneca PLC (AZN) Will Stay Independent For A Little While Longer 8/4/2014
Pfizer Inc. (PFE)’s Stake In Cellectis (ALCLS)’ Capital Is Welcomed By Its Shareholders 7/31/2014
Meda AB (MEDA-A.ST) Bags Rottapharm $3.08 Billion To Create A European Pharma Powerhouse 7/31/2014
AstraZeneca PLC (AZN) Scoops Up Almirall Lung Drugs For Up To $2.1 Billion 7/30/2014
Pfizer Inc. (PFE) CEO Aggressively Seeking Deals, Leaves Investors Guessing On AstraZeneca PLC (AZN) Intentions 7/30/2014
Cellectis (ALCLS) Sells Its Swedish Unit To Takara Bio For Undisclosed Amount 7/29/2014
AbbVie (ABBV) Trod Cautiously In Inversion Takeover Bid To Woo Drug Maker Shire 7/25/2014
Hikma Pharmaceuticals Buys Ben Venue Laboratories's Generic Manufacturing Site 7/24/2014
Stallergenes, S.A. (GENP.PA) Expands Latin American Presence With Acquisition Of Alergo Pharma S.R.L. In Argentina 7/21/2014
Roche (RHHBY) CEO Plans To Steer Clear Of Big Acquisitions 7/21/2014
Novartis AG (NVS), BWK Sell Stakes In Patch Maker LTS Lohmann Therapie-Systeme AG, Pockets $400 Million From Sale 7/17/2014
Sanofi (France) (SAN.PA) Quietly Held Talks With Abbott Laboratories (ABT), Mylan Inc. (MYL) About Mature Drugs 7/17/2014
Yibai Pharma To Acquire Horus C&K Pharma For $128 Million 7/16/2014
Chiltern Acquires Ockham And The Companies Merge Operations 7/15/2014
Phlexglobal Announces Acquisition By Bridgepoint Development Capital 7/15/2014
Hikma Pharmaceuticals Completes The Acquisition Of Assets Of Bedford Laboratories 7/15/2014
BioTie Therapies Corp. Will Not Exercise Option To Buy Neurelis, Neurelis Regains Rights To Intranasal Diazepam Program 7/11/2014
Valeant Pharmaceuticals International (VRX) Completes Sale Of Filler And Toxin Assets To Galderma 7/10/2014
AbbVie (ABBV) Forced To Retract Claims Of Shire Investor Support 7/9/2014
Salix Pharmaceuticals, Ltd. (SLXP) Scoops Up Cosmo Technologies For Tax Savings 7/9/2014
$100 Million Triple Life Sciences Deal For Newly Formed Concept Life Sciences 7/8/2014
Valeant Pharmaceuticals International (VRX) Completes Acquisition Of PreCision Dermatology 7/8/2014
AbbVie (ABBV)'s Battle For Shire: Why This Time It's Different 7/8/2014
Xellia Pharmaceuticals Expands Into The U.S. With Manufacturing Plant Buy 7/7/2014
Medicure Inc. (MCU) Grabs Minority Position In Pharmaceutical Manufacturer, Apicore LLC 7/3/2014
Jazz Pharmaceuticals plc (JAZZ) Wagers Up To $250 Million On Rare Disease Drug From Sigma-Tau Pharmaceuticals 7/3/2014
NicOx SA (COX.PA) Scoops Up Aciex Therapeutics In $120 Million Deal 7/2/2014
Cell Source Inc. Announces Acquisition And $3.6 Million Private Placement To Advance Novel Cancer Therapies 7/1/2014
AbbVie (ABBV) Takes Shire Courtship Trip To London 6/30/2014
Merz North America Pays $600 Million For Ultrasound Facelift Company Ulthera 6/30/2014
RedHill Biopharma Ltd. (RDHL) Acquires Phase 2 Oncology Drug MESUPRON® From Wilex AG (WL6.DE) 6/30/2014
Shire Entertained Many "Large Opportunities" Before AbbVie (ABBV) Bid 6/27/2014
Like GlaxoSmithKline (GSK), Sanofi (France) (SAN.PA) Mulls Sale Of Older Drugs, Plans To Put Dengue Vaccine Program In Separate Unit 6/27/2014
Valeant Pharmaceuticals International (VRX) Files Preliminary Proxy Statement For Special Meeting Of Shareholders To Approve Share Issuance In Proposed Acquisition Of Allergan Inc. (AGN) 6/25/2014
Warnex Inc. (CC:WNX) Received TSX-V Approval And Waives Due Diligence Condition To Amalgamation With Diagnos Inc. (ADK) 6/25/2014
AbbVie (ABBV) Urges Talks With Shire, May Have To Raise Bid To $51 Billion 6/25/2014
Shire To Set Out AstraZeneca PLC (AZN)-Style Defense Against AbbVie (ABBV)'s $46 Billion Bid 6/24/2014
Endo Buys DAVA Pharmaceuticals For $575 Million 6/24/2014
H. Lundbeck A/S (LUN.CO) Completes Acquisition Of Chelsea Therapeutics, Inc. (CHTP) 6/24/2014
Actavis (ACT) And Forest Laboratories, Inc. (FRX) Announce Tentative Election Deadline Of June 27, 2014 6/24/2014
Abbott Laboratories (ABT) Scoops Up Russian Drugmaker Veropharm For Between $395 To $495 Million Cash 6/24/2014
AbbVie (ABBV) Release: Shire Bid Could Move A Lot High Risk Puts Ceiling At £55/Share 6/23/2014
Lundbeck Inc. (LUN.CO) Successfully Completes Tender Offer For Chelsea Therapeutics, Inc. (CHTP) 6/23/2014
Shire plc Release: Management Spurns Three Offers From AbbVie (ABBV) , Fighting For Irish Independence, Call Monday Morning 6/23/2014
To Fend Off Pfizer Inc. (PFE), AstraZeneca PLC (AZN) Contemplating Sale Of Some Future Revenue From Existing Drugs 6/23/2014
Third Time Is Not The Charm As AbbVie (ABBV)'s $46 Billion Bid For Irish Rival Shire Rejected 6/23/2014
Rumor: Pfizer Inc. (PFE) May Be Interested In Buying Bristol-Myers Squibb Company (BMY) After Losing AstraZeneca PLC (AZN) 6/20/2014
While Valeant Pharmaceuticals International (VRX) Fights For Allergan Inc. (AGN), Allergan Takeover Bid For Shire "Imminent" 6/19/2014
New Drugs To Help Maintain Independence, Ward Off M&A Prospects: Actelion Ltd. (ALIOF.PK) CEO 6/19/2014
Trendlines Acquires Intellectual Property From Collaboration With Endo 6/18/2014
Irish-Based Shire Braces For Takeover Bids 6/18/2014
Pfizer Inc. (PFE) CFO Reveals Money Killed AstraZeneca PLC (AZN) Deal 6/16/2014
Commentary: BioSpace (DHX) Readers Sound Off On Big Pharma Takeovers 6/12/2014
Roche (RHHBY) Markets 5 Buildings On New Jersey Campus, Razing The Rest 6/11/2014
Chelsea Therapeutics, Inc. (CHTP) Announces The Expiration Of The Hart-Scott-Rodino Waiting Period In Relation To The Proposed Acquisition Of Chelsea Therapeutics By H. Lundbeck A/S (LUN.CO) 6/6/2014
Teva Pharmaceutical Industries Limited (TEVA) Buys Privately Held Labrys Biologics In Deal Worth $825 Million 6/4/2014
GlaxoSmithKline (GSK) Hunts For Suitors To Buy Older Drugs, Eyes Cash To Focus On Most Lucrative Areas Of Business 6/2/2014
Endo Completes Sale Of Early Stage Drug Discovery Portfolio 6/2/2014
TiGenix Completes The Sale Of Its Dutch Manufacturing Facility To PharmaCell BV 6/2/2014
Provence Technologies Acquires Synprosis 6/2/2014
Pfizer Inc. (PFE) Officially Ditches Pursuit Of AstraZeneca PLC (AZN) 5/29/2014
Sweden's Lund University Acquires Biomass Pretreatment Reactor From AdvanceBio Systems 5/27/2014
Recordati S.p.A Finalizes The Second Tranche Of Its Acquisition Of Opalia Pharma In Tunisia 5/27/2014
Loophole Offers Pfizer Inc. (PFE) A Risky Way Back Into A Deal With AstraZeneca PLC (AZN) 5/23/2014
H. Lundbeck A/S (LUN.CO) Commences Tender Offer For All Outstanding Shares Of Chelsea Therapeutics, Inc. (CHTP) 5/23/2014
BioAlliance Pharma, TopoTarget A/S To Merge, Combined Entity To Be Named Onxeo 5/22/2014
Clarification Regarding Pfizer Inc. (PFE) Statement 5/21/2014
AstraZeneca PLC (AZN) Rejects Pfizer Inc. (PFE)'s Final Offer 5/20/2014
Endo Completes Acquisition Of Rights To Sumavel® DosePro® 5/19/2014
Boston Scientific Corporation (BSX) Pays $415 Million For Bayer AG (BAYZF) Unit 5/19/2014
Abbott Laboratories (ABT) Expands Latin American Presence And Branded Generics Portfolio With Acquisition Of CFR Pharmaceuticals 5/16/2014
Pfizer Inc. (PFE) Exec Claims AstraZeneca PLC (AZN) Deal Will Not Put Lives At Risk 5/15/2014
AstraZeneca PLC (AZN) Leaves Door Ajar To Pfizer Inc. (PFE), Despite Hurdles 5/15/2014
Eurofins Shells Out $255 Million For U.S. Diagnostic Testing Company 5/14/2014
Origin Agritech Limited (SEED) Announces Receipt Of Acquisition Proposal 5/13/2014
Pfizer Inc. (PFE) Presses AstraZeneca PLC (AZN) Case As CEO Faces UK Grilling 5/13/2014
Shire Pharmaceuticals (SHPG) To Acquire Lumena Pharmaceuticals For Upfront Payment Of $260 Million In Cash 5/13/2014
Merck & Co., Inc. (MRK) Signs Sale Agreement With Santen Pharmaceutical For Merck's Ophthalmology Products In Japan And Key Markets In Europe And Asia Pacific 5/13/2014
Pfizer Inc. (PFE)'s Bid For AstraZeneca PLC (AZN) Shows That Big Pharma Is As Rotten As The Banks 5/13/2014
Merck KGaA (MKGAF.PK) Invests In Innovations For Future Growth 5/12/2014
Mallinckrodt Pharmaceuticals (MNK) And Questcor Pharmaceuticals, Inc. (Headquarters) (QCOR) Announce Early Termination Of HSR Act Waiting Period 5/12/2014